| P2093 | author name string | David H Peck | |
| | Paul Ziprin | |
| | Gretta Roberts | |
| | Nawar A Alkhamesi | |
| P2860 | cites work | Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding | Q27732644 |
| | New functions for the matrix metalloproteinases in cancer progression | Q29547738 |
| | Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging | Q33982101 |
| | Metastatic colorectal cancer: systemic treatment in the new millennium | Q35148795 |
| | Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy | Q37191386 |
| | Inhibition of peritoneal dissemination of tumor cells by cationized catalase in mice | Q40154923 |
| | ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention | Q40345488 |
| | Up regulation of ICAM-1 gene expression inhibits tumour growth and liver metastasis in colorectal carcinoma | Q40392058 |
| | Tumour-expressed CD43 (sialophorin) mediates tumourmesothelial cell adhesion. | Q40510813 |
| | General mechanisms of metastasis | Q41637450 |
| | Tumor Cell Invasion Inhibited by TIMP-2 | Q41679983 |
| | Cancer statistics, 2003. | Q43729872 |
| | MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure | Q43880520 |
| | Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer | Q45134437 |
| | Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. | Q45933135 |
| | Peritoneal nebulizer: a novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence | Q46602146 |
| | Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. | Q51916441 |
| | Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. | Q52223671 |
| | Isolation, culture and characterization of human peritoneal mesothelial cells | Q68835838 |
| | Extrapelvic colon--areas of failure in a reoperation series: implications for adjuvant therapy | Q70073418 |
| | Peritoneal carcinomatosis from adenocarcinoma of the colon | Q71140778 |
| | Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management | Q73125898 |
| | Gelatinase B (MMP-9) production and expression by stromal cells in the normal and adult thymus and experimental thymic lymphoma | Q73209074 |
| | Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix | Q73402334 |
| | Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1 | Q74336626 |
| | Peritoneum as the first-line of defense in carcinomatosis | Q79688002 |
| | ICAM-1 expression determines malignant potential of cancer | Q80458837 |
| | The matrix metalloproteinase system in oral squamous cell carcinoma | Q81595900 |
| | Colorectal cancer | Q93917269 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| P304 | page(s) | 377-384 | |
| P577 | publication date | 2007-10-08 | |
| P1433 | published in | Biomarker Insights | Q4915072 |
| P1476 | title | Induction of Proteases in Peritoneal Carcinomatosis, the Role of ICAM-1/CD43 Interaction | |
| P478 | volume | 2 | |